Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG33855

AP4B1 Knockout jurkat Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Blood (peripheral blood)

  • Disease:

    Acute lymphoblastic leukemia (ALL)

The AP4B1 Knockout Jurkat Polyclonal Cells are a CRISPR/Cas9-edited polyclonal T lymphocyte population designed for functional disruption of the AP4B1 gene. Derived from the Jurkat acute T cell leukemia line, these cells provide a loss-of-function system to investigate the AP-4 adaptor complex subunit beta, which governs vesicle trafficking from the trans-Golgi network to endosomes and lysosomes, interacting with cargo proteins such as ATG9A and sortilin to regulate autophagy and lysosomal enzyme delivery. This model is ideal for studying AP-4-dependent sorting in immune cells, dissecting autophagic flux and lysosomal function, and exploring mechanisms relevant to AP-4 deficiency syndrome and neurodevelopmental disorders. Applications include Western blotting, immunofluorescence, flow cytometry for LC3, and co-immunoprecipitation of AP-4 complex components.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Jurkat

    Cell Type

    T cell line

    Sex of Donor

    Male

    Age

    14 years

    Derived From Site

    In situ; Peripheral blood

    Gene Name

    AP4B1

    Gene Identifier

    NCBI Gene ID 10717

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The AP4B1 Knockout Jurkat Polyclonal Cells constitute a CRISPR/Cas9-mediated gene-disrupted polyclonal population in the Jurkat human T lymphocyte cell line, targeting the AP4B1 locus. This loss-of-function model is established as a heterogeneous pool, enabling functional studies of the adaptor protein complex 4 (AP-4) subunit beta in a T cell background without clonal expansion artifacts.

Jurkat cells, an immortalized T lymphocyte line derived from a patient with acute T cell leukemia, serve as a well-characterized model for T cell signaling, proliferation, and apoptosis. Their extensive use in immunological research provides a relevant context for examining intracellular trafficking pathways and their roles in immune cell function.

AP4B1 encodes the beta subunit of the AP-4 complex, which mediates clathrin-associated vesicle sorting from the trans-Golgi network to endosomes and lysosomes. Together with AP4E1, AP4M1, and AP4S1, AP4B1 facilitates the trafficking of cargoes such as ATG9A and sortilin, thereby regulating lysosomal enzyme delivery, LAMP1 localization, and autophagic flux. Disruption of AP4B1 impairs these processes, linking AP-4 function to endolysosomal homeostasis and autophagy.

In Jurkat lymphocytes, AP4B1 knockout disrupts AP-4-dependent cargo sorting, leading to diminished autophagic flux and aberrant lysosomal function. This phenotype is particularly relevant for modeling AP-4 deficiency syndrome??a neurodevelopmental disorder characterized by spastic paraplegia and intellectual disability??in an immune cell context, and may reveal lymphocyte-specific roles of the AP-4 pathway in proliferation or cytokine signaling.

Applications include validation of AP4B1 disruption via Western blot and RT-qPCR, immunofluorescence localization of AP-4, and measurement of autophagy markers (LC3) by flow cytometry. Researchers can employ autophagic flux assays, lysosomal enzyme activity tests, confocal microscopy for cargo trafficking, and co-immunoprecipitation to examine interactions with ATG9A, sortilin, or other AP-4 subunits. For further information or assistance, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)